News
21h
GlobalData on MSNDynavax’s shingles vaccine shows promise in trial against GSK’s Shingrix
Dynavax Technologies has revealed promising topline outcomes from the initial part of its Phase I/II clinical trial, ...
The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...
Shares in Dynavax Technologies Corporation closed 5% higher Thursday after the presentation of positive top-line results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results